Calls
1
u/anonmoneyguru
Reddit r/ValueInvesting
Win Rate
100.0%
return
+36.5%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Feb 21
$5.10
+36.5%
The author argues Lifeward is a $7.8m market cap turnaround led by CEO Mark Grant, who joined June 2025 with a MedTech track record including 25 years at Medtronic and skill at securing insurance coverage. UnitedHealthCare, Humana and Aetna now cover Lifeward's exoskeleton product at roughly $100k average cost, and the author expects the March 6 earnings call to give good forward guidance on increased sales. The improved AlterG Neo product is more cost-effective with wider market penetration, and Oramed is partnering to launch a first oral insulin with a reworked Phase 3 trial later this year or early 2027; passing that trial is described as a high-risk, high-reward lottery.
MedTech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/anonmoneyguru has 1 trade ideas tracked on Buzzberg across 1 tickers since February 2026. Most covered: LFWD.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
